Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
BIRCHVIEW CAPITAL LP | 11-14-2023 | 09-30-2023 | 52 | 117,495,182 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
BRISTOL-MYERS SQUIBB CO | COM | 1 | $41,573,898 | 716,297 | 0.04 | 0.03 | -12,288 | -1.69 | 09-30-2023 |
NEUROCRINE BIOSCIENCES INC | COM | 2 | $8,689,500 | 77,240 | 0.01 | 0.01 | -7,000 | -8.31 | 09-30-2023 |
BIODESIX INC COM RST | COM | 3 | $8,527,159 | 5,193,336 | 0.01 | 0.00 | 153,703 | 3.05 | 09-30-2023 |
PROTHENA CORP PLC | SHS | 4 | $8,181,946 | 169,574 | 0.01 | 0.01 | 13,463 | 8.62 | 09-30-2023 |